BioNTech, Pfizer Vaccine Neutralises Omicron with 3 Doses
Pfizer and BioNTech announced a three-shot course of Covid-19 vaccine was able to neutralise the new Omicron variant and can deliver an Omicron-based vaccine by...
Tag : BioNTech
BioNTech Plans to Send Five Million Vaccines to Taiwan
BioNTech had planned to send Taiwan 5 million Covid-19 vaccine doses by July under an original deal which collapsed in January, Taipei’s top diplomat in...
Japan Opens Mass Vaccination Centres Ahead of Olympics
Japan opened two mass vaccination centres on Monday as the country races to vaccinate most of its elderly population against Covid-19 before the start of...
BioNTech to Build mRNA Vaccine Manufacturing Site in Singapore
BioNTech said on Monday it plans to set up a regional headquarters and build a new manufacturing site for its vaccines based on messenger RNA...
Pfizer Asks US to Allow More Kids to Get Vaccinated
Drug giant Pfizer and its partner in developing the first COVID-19 vaccine that received emergency authorization in the US want to allow more adolescents to...
Pfizer Launch COVID-19 Vaccine Trial In Children Under 12
Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range...
US Loosens Pfizer Vaccine Shipping Regulations
US regulators are allowing Pfizer’s COVID-19 vaccine to be shipped and stored at less-frigid temperatures, which should ease distribution and administration of one of the two vaccines...
Pfizer to Test Covid-19 Vaccine Booster for South African Variant
A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically...
Singapore Receives First Batch of Pfizer Covid-19 Vaccine
Singapore is the first Asian country to receive its first shipment of Pfizer-BioNTech Covid-19 vaccine developed by Pfizer Inc. and its German partner company, BioNTech. The Straits Times...
BioNTech Covid-19 Vaccine Effective Against New Coronavirus Strain
BioNTech CEO Ugur Sahin said on Monday he was confident a COVID-19 vaccine co-developed by his company would be effective against a variant of the coronavirus...